Lifeboat Foundation

More on DARPA’s Quantum Biosystem program “RadioBio”
During Phase 1, performers will be asked to theoretically model and simulate hypothesized electromagnetic signaling pathways and then experimentally test those theoretical predictions.

In Phase 2, the goal would be to independently develop test beds to replicate, confirm, and demonstrate the pathways modeled in Phase 1 and reveal design principles potentially relevant to biological or other applications aka can we enable human to human communication without a device.

ARLINGTON, Va. Defense Advanced Research Projects Agency (DARPA) officials launched a new program that seeks to establish if purposeful electromagnetic wave signaling between biological cells exists — and if evidence supports that it does — to determine what information is being transferred.

Continue reading “RadioBio research effort aims to find the role of electromagnetic signaling in biological systems” »

So true; as many of us have stated that the infrastructure for QC is a must 1st. A good video to review; as many of the themes are often repeated in many commentaries as well as this video provides some additional insights on QC.

Orbital Insight founder and NASA veteran James Crawford on why it’s time to shelve “moonshots.”

The problems that I have seen when limiting the topic of quantum mechanics to the human mind topic is that the relationship around Quantum Mechanics to biology is missed completely. For example, it has only be in the recent few years that scientists began to understand Quantum Mechanics Action of ELF electromagnetic fields and its relationship to human cells. And, this find has open valuable research in how cells can (through electromagnetic fields can spin a low temperatures) mimic telepathy communicating between the human cells.

Nobody understands what consciousness is or how it works. Nobody understands quantum mechanics either. Could that be more than coincidence?

‘Mars 2117 Project’ is set to be developed and executed in partnership with major international research institutions.

14 Feb 2017 19:23 GMT Middle East, UAE, Science & Technology.

After three years of developing a brand new rocket, aerospace startup Rocket Lab has finally transported a finished vehicle to the New Zealand launch pad where it will take its first flight. The rocket, called the Electron, has been tested on the ground over the last year but has never been flown to space before. Over the next couple of months, Rocket Lab will conduct a series of test launches of the vehicle to verify that it’s ready to carry payloads into orbit for commercial customers.

Compared to other major commercial rockets like the Falcon 9 or the Atlas V, the Electron is pretty small — only 55 feet tall and and around 4 feet in diameter. That’s because the vehicle is specifically designed to launch small satellites. The vehicle can carry payloads ranging from 330 to 500 pounds into an orbit more than 300 miles up. That’s a relatively light lift contrasted with the Falcon 9, which can carry more than 50,000 pounds into lower Earth orbit.

The Broad Institute in Cambridge, Mass., will retain potentially lucrative rights to a powerful gene-editing technique that could lead to major advances in medicine and agriculture, the federal Patent and Trademark Office ruled on Wednesday.

The decision, in a bitterly fought dispute closely watched by scientists and the biotechnology industry, was a blow to the University of California, often said to be the birthplace of the technique, which is known as Crispr-Cas9.

An appeals board of the patent office ruled that the gene-editing inventions claimed by the two institutions were separate and do not overlap.

Scientists have discovered a groundbreaking immunotherapy combination that kills brain cancer, promotes long-term immunity and is highly effective against breast cancer and myeloma.

Researchers at the Children’s Hospital of Eastern Ontario (CHEO) in Ottawa had the promising findings published Wednesday in the journal ‘Nature Communications’.

The study outlines how the team developed a unique combination of drugs known as SMAC Mimetics and immune checkpoint inhibitors (ICIs) that produce high kill rates for cancer tumor cells in mice.

Feb. 15 (UPI) — The U.S. National Aeronautics and Space Administration on Wednesday indicated that President Donald Trump may want the United States to resurrect its pioneering spirit in outer space — much the same way another American leader did five decades ago.

Acting NASA Administrator Robert M. Lightfoot, Jr., sent a memo to employees Wednesday saying he had instructed the agency to work up a feasibility report on adding astronauts to its planned EM-1 flight late next year.

The mission, which is currently unmanned, will launch NASA’s new Space Launch System rocket with an Orion capsule. The spacecraft would orbit the moon and return to Earth. The agency’s EM-2 mission, scheduled for years later, was supposed to be the spaceflight to carry humans.

Continue reading “Trump may get Kennedy-esque with earlier return to moon” »